FDA: Pancreatic enzyme medically necessary

Pancreatic enzyme replacement products have been around for a long time, but have largely existed as nutritional supplements. Yesterday, an FDA official said the products are medically necessary, which might mean an approval is in store for Solvay's Creon. Creon and similar products aim to help patients with chronic pancreatitis, cystic fibrosis and other conditions that require replacement of pancreatic enzymes essential for digestion. Report

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.